相似文献
1
Hypertension after renal transplant.
J Clin Hypertens (Greenwich). 2007 Jul;9(7):538-45. doi: 10.1111/j.1524-6175.2007.06588.x.
2
[The kidney and hypertension].
Z Arztl Fortbild (Jena). 1994 Jan;88(1):31-6.
3
[Sequelae of hypertenson: kidney disease].
Internist (Berl). 2006 Mar;47(3):226, 228-32. doi: 10.1007/s00108-005-1575-6.
4
Iliac artery obliteration as a cause of renovascular hypertension in kidney graft recipients: A difficult and uncommon diagnosis.
Nefrologia. 2015;35(4):413-4. doi: 10.1016/j.nefro.2015.06.007. Epub 2015 Jul 29.
5
[Hypertension in diabetes mellitus. Causes, follow-up and treatment].
Med Klin (Munich). 1994 Jun 15;89(6):330-8.
6
[Renal diagnostics in arterial hypertension].
MMW Fortschr Med. 2015 Jul 23;157(13):65-7. doi: 10.1007/s15006-015-3357-y.
7
[Differential diagnosis and therapy of essential hypertension].
Z Arztl Fortbild (Jena). 1996 May;90(3):213-20.
8
Pediatric post-transplant hypertension: a review of current standards of care.
Child Nephrol Urol. 1992;12(2-3):139-46.
9
Aspects of hypertension in renal allograft recipients. A study of 1000 live renal transplants.
Br J Urol. 1993 Mar;71(3):256-8. doi: 10.1111/j.1464-410x.1993.tb15938.x.
10
Hypertension and renal disease.
Practitioner. 1993 Feb;237(1523):173-5.
引用本文的文献
1
Non-Immunologic Causes of Late Death-Censored Kidney Graft Failure: A Personalized Approach.
J Pers Med. 2022 Aug 1;12(8):1271. doi: 10.3390/jpm12081271.
2
Hypertension in chronic kidney disease: navigating the evidence.
Int J Hypertens. 2011;2011:132405. doi: 10.4061/2011/132405. Epub 2011 May 24.
3
Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.
Curr Diab Rep. 2008 Jun;8(3):221-7. doi: 10.1007/s11892-008-0038-6.
本文引用的文献
1
Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
MMWR Morb Mortal Wkly Rep. 2007 Feb 23;56(7):137-41.
2
The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients.
Transplant Proc. 2006 Jun;38(5):1323-6. doi: 10.1016/j.transproceed.2006.02.103.
3
Office blood pressure measurements overestimate blood pressure control in renal transplant patients.
Blood Press Monit. 2006 Jun;11(3):125-33. doi: 10.1097/01.mbp.0000209080.24870.2d.
4
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
J Am Soc Nephrol. 2006 Mar;17(3):889-99. doi: 10.1681/ASN.2005090955. Epub 2006 Feb 15.
5
A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.
Nephrol Dial Transplant. 2006 May;21(5):1389-94. doi: 10.1093/ndt/gfk058. Epub 2006 Jan 23.
6
Improved long-term outcomes after renal transplantation associated with blood pressure control.
Am J Transplant. 2005 Nov;5(11):2725-31. doi: 10.1111/j.1600-6143.2005.01093.x.
7
Transplant renal artery stenosis: outcome after percutaneous intervention.
J Vasc Interv Radiol. 2004 Dec;15(12):1407-13. doi: 10.1097/01.RVI.0000141338.62574.F4.
8
Hypertension after kidney transplantation.
Am J Kidney Dis. 2004 Jun;43(6):1071-81. doi: 10.1053/j.ajkd.2004.03.013.
9
Weight gain after renal transplantation is a risk factor for patient and graft outcome.
Transplantation. 2004 May 15;77(9):1381-5. doi: 10.1097/01.tp.0000120949.86038.62.
10
Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients?
Transplantation. 2003 Dec 15;76(11):1640-2. doi: 10.1097/01.TP.0000091288.19441.E2.
Zotero 插件